# eHIV Review – no-cost CME — Accredited by Johns Hopkins

> Accredited medical education app for HIV care and treatment updates. (iPhone/iPad app by DKBmed LLC.)

- Source: https://appshunter.io/ios/app/ehiv-review-no-cost-cme/id891709230 (this page in markdown: same URL + `.md`)
- Developer: [DKBmed LLC](https://appshunter.io/developer/505074665)
- Category: Medical, Education
- Price: Free
- Rating: 5.00/5 from 3 App Store ratings
- Age rating: 12+
- Requires: iOS 10.0 · 31 MB
- Languages: American English
- Released: 2014-06-29
- Data updated: 2026-06-10
- Monetization: free
- User reviews in markdown: https://appshunter.io/ios/app/ehiv-review-no-cost-cme/id891709230/reviews.md

## What is eHIV Review?

eHIV Review is part of the highly successful eLiterature Review series. Over 50,000 health care providers are subscribed to eLiterature Review in areas such as viral hepatitis, primary care, pulmonology, cystic fibrosis, multiple sclerosis, and diabetes. Join your colleagues in this highly-rated educational program.

eHIV Review Volume 5 covers key topics such as:
-Screen every adult for HIV
-Have better discussions about PrEP
-Understand new therapies that can improve outcomes in aging populations with HIV

It is practically impossible for time-pressed clinicians to stay current with new clinical developments by reading medical literature alone, despite the value of doing so. To address this, the Johns Hopkins University School of Medicine (JHUSOM), in partnership with DKBmed, has enhanced the way clinicians receive this vital information through our highly successful eLiterature Review series, spanning a variety of disease states and covering a wide range of clinical expertise. The nuances of each disease require a tailored approach to facilitate optimal learning techniques and knowledge retention. In previous eLiterature Review, some programs have been specifically directed to the specialist practitioner (eg, eCysticFibrosis, eNeonatalogy), but the majority have targeted a combination of both specialists and primary care clinicians that treat patients with chronic disease (eg, eDiabetes, eViralHepatitis).  

"eHIV Review condenses the latest research findings about the care of people with HIV and emerging antiretroviral therapies to help doctors make the most effective treatment choices for their patients, as well as identify those who should be screened." 
-Alysse Wurcel, MD, Assistant Professor, Tufts Medical Center Division of Geographic Medicine and Infectious Diseases

## Key features

- Accredited Continuing Medical Education (CME)
- Covers HIV screening and PrEP
- Discusses new therapies for aging HIV populations
- Condensed latest research findings
- Tailored learning techniques for knowledge retention


## Frequently asked questions about eHIV Review

### What is eHIV Review?

eHIV Review is a free medical education app that provides accredited continuing medical education (CME) for healthcare providers focused on HIV care. It aims to help clinicians stay current with the latest research and treatment choices.

### What topics does eHIV Review cover?

eHIV Review covers key topics such as screening every adult for HIV, having better discussions about PrEP, and understanding new therapies that can improve outcomes in aging populations with HIV.

### Is eHIV Review accredited?

Yes, eHIV Review is accredited by Johns Hopkins University School of Medicine, offering accredited continuing medical education (CME).

### Who developed eHIV Review?

eHIV Review was developed by DKBmed LLC in partnership with the Johns Hopkins University School of Medicine.

### What devices does eHIV Review support?

eHIV Review is available for iPhone, iPad, and iPod devices.

### How often is eHIV Review updated?

The latest version of eHIV Review is 4.1, and it was last updated on March 11, 2020.

### What is the age rating for eHIV Review?

eHIV Review has an age rating of 12+, making it suitable for a broad audience of healthcare professionals.

### How does eHIV Review help clinicians stay current?

eHIV Review condenses the latest research findings about HIV care and emerging antiretroviral therapies, making it easier for time-pressed clinicians to stay informed without solely relying on reading medical literature.

## Version history (last 5 releases)

### 4.1 — 2020-03-11

Minor bugs fixed

### 4.0 — 2019-12-22

Small bugs fixed and performance improved.

### 3.0 — 2018-08-10

Updated UI/UX.
Added saving progress.

### 2.0.0 — 2014-07-18

Minor copy updates.

### 1.0.0 — 2014-06-27

No release notes.

## Apps similar to eHIV Review

| App | Rating | Price | Category |
| --- | --- | --- | --- |
| [Infectious Diseases @PoC](https://appshunter.io/ios/app/infectious-diseases-poc/id1437673838) | — | Free | Medical |
| [HIV Clinical Job Aids](https://appshunter.io/ios/app/hiv-clinical-job-aids/id1544602572) | 4.0 (1) | Free | Medical |
| [5 Minute Infectious Diseases](https://appshunter.io/ios/app/5-minute-infectious-diseases/id1137518792) | 4.8 (15) | Free | Medical |
| [Life4Me+](https://appshunter.io/ios/app/life4me-plus/id1192270145) | 5.0 (5) | Free | Medical |
| [Radiology - Head&Neck Anatomy](https://appshunter.io/ios/app/radiology-head-and-neck-anatomy/id1364480176) | 5.0 (1) | $8.99 | Medical |
| [S-ON](https://appshunter.io/ios/app/s-on/id1592554898) | — | Free | Medical |

## More apps by DKBmed LLC

- [eCysticFibrosis Review](https://appshunter.io/ios/app/ecysticfibrosis-review/id686209701)
- [eMultipleSclerosis Review](https://appshunter.io/ios/app/emultiplesclerosis-review/id983062229)
- [eViralHepatitis Review](https://appshunter.io/ios/app/eviralhepatitis-review/id1053602206)
- [PHQ-9 Test](https://appshunter.io/ios/app/phq-9-test/id1178174071)
- [ePulmonology Review](https://appshunter.io/ios/app/epulmonology-review/id1356508703)

All apps by DKBmed LLC: https://appshunter.io/developer/505074665

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-10.*